Impaired Neurotransmitter Release in Alzheimer’s and Parkinson’s Diseases

Publisher： Karger

E-ISSN： 1660-2862|7|1-3|80-83

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.7, Iss.1-3, 2010-02, pp. : 80-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Misframed Proteins and Neurodegeneration: A Novel View on Alzheimer’s and Parkinson’s Diseases

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-02 ,pp. : 76-79

Karger

Access to resources Recommend Favorite

Biomarkers for the Early Detection of Parkinson’s and Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 133-136

Karger

Access to resources Recommend Favorite

Plasma F2A Isoprostane Levels in Alzheimer’s and Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 4, Iss. 6, 2007-10 ,pp. : 403-405

Karger

Access to resources Recommend Favorite

Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer’s and Parkinson’s diseases

By Nakamura Tomohiro  

Apoptosis, Vol. 15, Iss. 11, 2010-11 ,pp. : 1354-1363

Springer Publishing Company

Access to resources Recommend Favorite

Activation of the Unfolded Protein Response Is an Early Event in Alzheimer’s and Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-02 ,pp. : 212-215

Karger

Access to resources Recommend Favorite